NRx Pharmaceuticals is a clinical-stage biopharmaceutical enterprise focused on developing novel therapeutics targeting central nervous system disorders, psychiatric conditions such as bipolar depression and suicidal ideation, and severe respiratory diseases. The company leverages its scientific platform to advance late-stage clinical candidates through regulatory pathways toward commercialization and patient care integration.